Back to search results

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Abroad (travel likely)RecruitingPHASE3

Conditions

Advanced Ovarian Carcinoma · Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Endometrioid Tumor · Fallopian Tube Serous Neoplasm · Fallopian Tube Transitional Cell Carcinoma · Ovarian Clear Cell Adenocarcinoma · Ovarian Endometrioid Adenocarcinoma · Ovarian Serous Adenocarcinoma · Ovarian Transitional Cell Carcinoma · Primary Peritoneal Clear Cell Adenocarcinoma · Primary Peritoneal Endometrioid Adenocarcinoma · Primary Peritoneal Serous Adenocarcinoma · Primary Peritoneal Transitional Cell Carcinoma · Stage IIIC Fallopian Tube Cancer AJCC v8 · Stage IIIC Ovarian Cancer AJCC v8 · Stage IIIC Primary Peritoneal Cancer AJCC v8 · Stage IV Fallopian Tube Cancer AJCC v8 · Stage IV Ovarian Cancer AJCC v8 · Stage IV Primary Peritoneal Cancer AJCC v8 · Stage IVA Fallopian Tube Cancer AJCC v8 · Stage IVA Ovarian Cancer AJCC v8 · Stage IVA Primary Peritoneal Cancer AJCC v8 · Stage IVB Fallopian Tube Cancer AJCC v8 · Stage IVB Ovarian Cancer AJCC v8 · Stage IVB Primary Peritoneal Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Abdulrahman Sinno, MD) · ak.sinno@med.miami.edu
    Contact: Principal Investigator (Abdulrahman Sinno, MD)

  • Cleveland Clinic Foundation - Florida, Weston, Florida, United States

    Contact: Study coordinator (Joel Cardenas, MD) · cardenj3@ccf.org
    Contact: Principal Investigator (Joel Cardenas)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Alexander Melamed, MD) · alexander.melamed@mgh.harvard.edu
    Contact: Principal Investigator (Alexander Melamed)

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Neil Horowitz, MD) · nhorowitz@partners.org · 877-338-7425
    Contact: Study coordinator (Neil Horowitz) · nhorowitz@mgh.harvard.edu · (877) 338-7425

  • NYU Langone Health, Mineola, New York, United States

    Contact: Study coordinator (Edward Jimenez, MD) · edward.jimenez@nyulangone.org
    Contact: Principal Investigator (Edward Jimenez, MD)

  • Columbia University Medical Center, New York, New York, United States

    Contact: Study coordinator (Jason D. Wright, MD) · jw2459@cumc.columbia.edu
    Contact: Principal Investigator (Jason D. Wright, MD)

  • Duke, Durham, North Carolina, United States

    Contact: Study coordinator (Leah McNally, MD) · Leah.McNally018@duke.edu · 919-780-7070
    Contact: Principal Investigator (Leah McNally, MD)

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Chad Michener, MD) · michenc@ccf.org
    Contact: Principal Investigator (Chad Michener)

  • St. Luke's University Health Network, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Nicholas Taylor, MD) · nicholas.taylor@sluhn.org
    Contact: Principal Investigator (Nicholas Taylor, MD)

  • Lyndon Baines Johnson General, Houston, Texas, United States

    Contact: Study coordinator (Jose Rauh-Hain, MD) · jarauh@mdanderson.org · 713-794-1759
    Contact: Principal Investigator (Jose Rauh-Hain, MD)

  • Houston Methodist, Houston, Texas, United States

    Contact: Study coordinator (Pedro Ramirez, MD) · pramirez3@houstonmethodist.org
    Contact: Principal Investigator (Pedro Ramirez)

  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Jose A. Rauh-Hain, MD,MPH) · jarauh@mdanderson.org · 713-794-1759
    Contact: Principal Investigator (Jose A. Rauh-Hain)

  • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

  • Arthur J.E. Child Comprehensive Cancer Centre - Calgary, Calgary, Canada

    Contact: Study coordinator (Gregg Nelson, MD) · gregg.nelson@albertahealthservices.ca
    Contact: Principal Investigator (Gregg Nelson)

  • University Health Network - Princess Margaret Cancer Centre, Toronto, Canada

    Contact: Study coordinator (Liat Hogen, MD) · liat.hogen@uhn.ca
    Contact: Principal Investigator (Liat Hogen)

  • Sant'Orsola Hospital di Bologna, Bologna, Italy

    Contact: Study coordinator (Pierandrea De laco, MD) · pierandrea.deiaco@unibo.it
    Contact: Principal Investigator (Pierandrea De laco)

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Contact: Study coordinator (Anna Fagotti, MD) · anna.fagotti@unicatt.it
    Contact: Principal Investigator (Anna Fagotti)

  • Instituto Nacional de Cancerología (Mexico), Tlalpan, Mexico

    Contact: Study coordinator (David Ortiz, MD) · islasurgery@hotmail.com
    Contact: Principal Investigator (David Isla Ortiz)

  • Amsterdam UMC - Locatie AMC | H5Zuid 154, Amsterdam, Netherlands

    Contact: Study coordinator (Luc van Lonkhuijzen, MD)
    Contact: Principal Investigator (Luc van Lonkhuijzen)
Study leads

  • Jose A Rauh-Hain

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)